Business

Eli Lilly shares rise as Zepbound weight-loss test shows solid success

Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.

4 December 2024

Health news

Over 800 million people have diabetes globally. What about in Europe?

Diabetes rates have doubled globally in the last three decades, a new study suggests, here’s what to know about the situation in Europe.

14 November 2024

Health news

Weight-loss drugs like Ozempic may reduce opioid overdose rates

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.

17 October 2024

wellbeing

Intense weekend exercise may have similar benefits to regular workouts

Both regular exercise and intense weekend exercise were found to lower the risk of more than 200 diseases, including hypertension and diabetes.

26 September 2024

Business

Novo Nordisk boss in US grilling over prices for weight-loss drugs

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.

25 September 2024

Health news

Insulin resistance linked to risk of over 30 diseases and early death

A recent study found that insulin resistance is associated with an increased risk of 26 conditions, a lower risk of five more, and early death in women.

9 September 2024

Business

Novo Nordisk: Earnings trimmed as rivals seek to enter market

Novo Nordisk missed earnings expectations in the second quarter due to growing competition and increased costs from capacity expansions. The company also downgraded its profit outlook for 2024.

7 August 2024

Health news

Diabetes-reversing treatment boosts insulin-producing cells by 700%

A new preclinical study found a combination treatment that significantly increases insulin-producing cells, effectively reversing diabetes.

22 July 2024

Business

Wegovy and Ozempic maker Novo Nordisk plans billion-dollar US plant

Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.

25 June 2024

Health news

Intermittent fasting may help type 2 diabetics control blood sugar

A new study found that intermittent fasting may be an effective initial intervention for type 2 diabetics instead of medication.

24 June 2024

Business

Novo Nordisk beats Q1 estimates as weight-loss drugs drive growth

Danish pharmaceutical titan Novo Nordisk, the maker of Ozempic and Wegovy, announces a significant year-over-year increase in net profit and sales for the first quarter of 2024.

2 May 2024

Health news

Oral insulin could replace injections for diabetics, new study finds

A new form of oral insulin, which may soon be tested in humans, can be taken as an alternative to syringes or insulin pumps.

2 February 2024

Nutrition

Glucose monitors are gaining popularity among those without diabetes

This stick-on arm patch is among the new generation of glucose monitors.

5 January 2024

Health news

Americans turn to alternatives amid Ozempic shortage

Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug.

4 December 2023

Business

AstraZeneca announces new anti-obesity drug deal and positive profit

AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug.

10 November 2023

Nutrition

Eating red meat linked to increased risk of type 2 diabetes - study

Replacing red meat with plant-based protein sources like nuts and vegetables may reduce the risk of type 2 diabetes, according to a new study.

19 October 2023

Business

Denmark's Novo Nordisk and South Africa's Aspen to produce insulin for African patients

Last year, the World Health Organization estimated that there are 24 million adults living with diabetes in Africa, saying the number is expected to rise to 55 million by 2045.

20 September 2023

Health news

Anti-obesity drug market booming with new class of popular drugs

Designed to treat obesity, a new class of drugs is also an opportunity for investors.

24 August 2023

Health news

This new weight loss drug is set to rival Ozempic and Wegovy

Ozempic has a new rival: Mounjaro, also a diabetes drug, has led to average weight losses of 15 to 24 kg.

28 April 2023

Health news

Coffee lover? High caffeine levels may curb body fat and diabetes risk

Scientists found genetic evidence that higher blood caffeine levels reduce body weight and diabetes risk. What does it mean for coffee addicts?

16 March 2023